๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

โœ Scribed by Feldman, David; Zhao, Xiao-Yan; Malloy, Peter J.; Krishnan, Aruna V.; Swami, Srilatha; Navone, Nora M.; Peehl, Donna M.


Book ID
109828322
Publisher
Nature Publishing Group
Year
2000
Tongue
English
Weight
600 KB
Volume
6
Category
Article
ISSN
1078-8956

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Constitutive activation of the androgen
โœ Jocelyn Cรฉraline; Marion D. Cruchant; Eva Erdmann; Philippe Erbs; Jean-Emmanuel ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 278 KB ๐Ÿ‘ 2 views

## Abstract Androgen receptor (AR) mutations that modify both the ligand binding and the transactivation capacities of the AR represent one of the mechanisms involved in the transition of prostate cancer (PCa) from androgenโ€dependent to androgenโ€independent growth. We use a yeastโ€based functional a

5ฮฑ-androstane-3ฮฑ,17ฮฒ-diol supports human
โœ Qing Yang; Mark A. Titus; Kar-Ming Fung; Hsueh-Kung Lin ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 323 KB ๐Ÿ‘ 1 views

## Abstract Androgen and androgen receptor (AR) are involved in growth of normal prostate and development of prostatic diseases including prostate cancer. Androgen deprivation therapy is used for treating advanced prostate cancer. This therapeutic approach focuses on suppressing the accumulation of

The androgen receptor can signal through
โœ Liang Schweizer; Cheryl A Rizzo; Thomas E Spires; J Suso Platero; Qiuyan Wu; Tai ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› BioMed Central ๐ŸŒ English โš– 816 KB

## Background A crucial event in Prostate Cancer progression is the conversion from a hormone-sensitive to a hormone-refractory disease state. Correlating with this transition, androgen receptor (AR) amplification and mutations are often observed in patients failing hormonal ablation therapies. ฮฒ-C